Strive Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-359
Closed -$274K 97
2025
Q3
$274K Sell
359
-112
-24% -$83.3K 0.15% 65
2025
Q2
$367K Sell
471
-281
-37% -$218K 0.22% 59
2025
Q1
$621K Buy
752
+154
+26% +$128K 0.43% 58
2024
Q4
$462K Buy
+598
New +$495K 0.35% 81

Other funds holding LLY

Strive Asset Management's LLY Position: Q4 2025 in Review

Strive Asset Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 359 shares — an estimated $274K sold.

Strive Asset Management first reported a position in LLY in Q4 2024 and held it in 4 quarters. The position peaked at $621K in Q1 2025. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Strive Asset Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Strive Asset Management sold 359 Eli Lilly shares in Q4 2025, an estimated $274K.
  • Strive Asset Management first reported a position in Eli Lilly in Q4 2024 and held it in 4 quarters.
  • Strive Asset Management's Eli Lilly position peaked at $621K in Q1 2025.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Strive Asset Management's 13F filing for Q4 2025.